NCT02949674View on ClinicalTrials.gov

Ropivacaine Versus Bupivacaine as Preemptive Analgesia in Surgical Site in Ankle Fracture Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

April 30, 2017

Conditions
Ankle FracturesPain, PostoperativeLocal Infiltration
Interventions
DRUG

Ropivacaine

It will be used as a analgesic dose in surgical site before surgery.

DRUG

Bupivacaine

It will be used as a analgesic dose in surgical site before surgery.

Trial Locations (1)

07020

UMAE Dr. Victorio de La Fuente Narvaez, Mexico City

All Listed Sponsors
lead

Instituto Mexicano del Seguro Social

OTHER_GOV

NCT02949674 - Ropivacaine Versus Bupivacaine as Preemptive Analgesia in Surgical Site in Ankle Fracture Patients | Biotech Hunter | Biotech Hunter